相关实验视频

Updated: Aug 7, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

在乳腺癌中CIN状态分类的联合全球和本地解释方法

Liangliang Liu¹, Pei Zhang¹, Zhihong Liu¹

¹College of Information and Management Science, Henan Agricultural University, Zhengzhou, Henan 450046, PR China.

|April 2, 2024

概括

这项研究介绍了GL_XGBoost,这是一种使用微RNA (miRNA) 预测乳腺癌染色体不稳定性的新方法. 该方法通过从miRNA表达特征准确识别CIN状态来提高患者的生存率.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

乳腺癌是全球癌症诊断的主要原因之一.
微RNAs (miRNAs) 在各种癌症中与染色体不稳定性 (CIN) 有关.
准确预测CIN状态对于改善乳腺癌患者的治疗结果至关重要.

研究的目的:

开发和验证一种使用miRNA表达数据预测乳腺癌中CIN状态的新计算方法.
提高乳腺癌预测模型的可解释性 CIN.
为了确定与乳腺癌中CIN相关的关键miRNAs.

主要方法:

开发了一种联合的全球和本地解释方法,GL_XGBoost.
GL_XGBoost集成了用于预测的 eXtreme Gradient Boosting (XGBoost) 和用于特征选择和解释的 SHapley 添加式扩展 (SHAP).
该模型使用TCGA-BRCA数据集进行了验证.

主要成果:

在预测CIN状态时,GL_XGBoost实现了78.57%的准确度和0.87的曲线下面积 (AUC).
SHAP分析有效地确定了与CIN有很强的相关性miRNA特征.
综合可视化提供了全球和本地模型的解释性.

结论:

GL_XGBoost提供了一种有效和可解释的方法,用于从miRNA数据中预测乳腺癌CIN.
该方法有助于理解miRNAs和CIN之间的微观关系.
这种方法有可能改善乳腺癌患者的分层和生存预测.

关键词:

乳腺癌乳腺癌乳腺癌染色体的不稳定性这就是 SHAP SHAP 的意思.在XGBoost中使用.这就是miRNAs.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...